A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis – Anervea
Revolutionary Breakthrough in NASH Management: New Treatment Offers Unprecedented Hope for Liver Fibrosis Patients Pune, March 17, 2024 (GLOBE NEWSWIRE) — The recent FDA approval of Resmetirom, developed by Madrigal Pharmaceuticals, has sent ripples of… Read More »A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis – Anervea





